Immusoft immusoft.com

Immusoft is a biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The first ISP-based treatment Immusoft will advance to human trials is a therapy for MPS I, a rare, genetic, lysosomal storage disease. ISP technology will be used to make patient's immune cells continually secrete a-L-iduronidase (IDUA).

Immusoft is a biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The first ISP-based treatment Immusoft will advance to human trials is a therapy for MPS I, a rare, geneti...Show all

See All Exits Recent Exits

Phone: 206-931-0262

Fax:

454 N 34th St.

Seattle, 98103
Washington, United States

Immusoft - Investments & Acquisitions

Show Real Data Immusoft Investments
See all Recent Investments
Date Company Round Amount Co-investors
2016-03-08Discovery GenomicsAcquired
See all 1 investments